These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 1372076)

  • 1. The impact of recent advances in diagnostic technology on the clinical presentation of phaeochromocytoma.
    Edwards GA; Smythe GA; Graham PE; Lazarus L
    Med J Aust; 1992 Feb; 156(3):153-7. PubMed ID: 1372076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary catecholamines and the diagnosis of phaeochromocytoma in Auckland.
    McNeil AR; Woollard GA
    N Z Med J; 1997 Sep; 110(1051):331-3. PubMed ID: 9323371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the clonidine suppression test in the diagnosis of phaeochromocytoma.
    McHenry CM; Hunter SJ; McCormick MT; Russell CF; Smye MG; Atkinson AB
    J Hum Hypertens; 2011 Jul; 25(7):451-6. PubMed ID: 20811397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phaeochromocytomas secreting adrenaline but not noradrenaline do not cause hypertension and require precise adrenaline measurement for diagnosis.
    Bachmann AW; Hawkins PG; Gordon RD
    Clin Exp Pharmacol Physiol; 1989 Apr; 16(4):275-9. PubMed ID: 2743619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences between sporadic and multiple endocrine neoplasia type 2A phaeochromocytoma.
    Pomares FJ; Cañas R; Rodriguez JM; Hernandez AM; Parrilla P; Tebar FJ
    Clin Endocrinol (Oxf); 1998 Feb; 48(2):195-200. PubMed ID: 9579232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of venous sampling in locating a phaeochromocytoma.
    Allison DJ; Brown MJ; Jones DH; Timmis JB
    Br Med J (Clin Res Ed); 1983 Apr; 286(6371):1122-4. PubMed ID: 6404350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phaeochromocytoma.
    Foo M; Burton BJ; Ahmed R
    Br J Hosp Med; 1995 Oct 4-17; 54(7):318-21. PubMed ID: 8556210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secretion of dopa in phaeochromocytoma.
    Louis WJ; Doyle AE; Heath WC; Robinson MJ
    Br Med J; 1972 Nov; 4(5836):325-7. PubMed ID: 4637512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemical detection of phaeochromocytoma: should we still be measuring urinary HMMA?
    Peaston RT; Lai LC
    J Clin Pathol; 1993 Aug; 46(8):734-7. PubMed ID: 8408698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High permanent plasma adrenaline levels: a marker of adrenal medullary disease in medullary thyroid carcinoma.
    Vistelle R; Grulet H; Gibold C; Chaufour-Higel B; Delemer B; Fay R; Delisle MJ; Caron J
    Clin Endocrinol (Oxf); 1991 Feb; 34(2):133-8. PubMed ID: 1673649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. No correlation between phaeochromocytoma catecholamine secretion and granule ultrastructure.
    Mihai R; Wong NA; Luckett M; Sheffield E; Farndon JR
    Br J Surg; 1998 Dec; 85(12):1681-5. PubMed ID: 9876074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased sensitivity and accuracy of phaeochromocytoma diagnosis achieved by use of plasma-adrenaline estimations and a pentolinium-suppression test.
    Brown MJ; Allison DJ; Jenner DA; Lewis PJ; Dollery CT
    Lancet; 1981 Jan; 1(8213):174-7. PubMed ID: 6109856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Results of screening for phaeochromocytoma in 17 hypertensive patients with episodic symptoms.
    Hull RD; Sebel E; Stokes GS; Chalmers JP; Hinterberger H
    Med J Aust; 1974 Mar; 1(11):381-5. PubMed ID: 4829549
    [No Abstract]   [Full Text] [Related]  

  • 14. Biochemical diagnosis of phaeochromocytoma: two instructive case reports.
    Stewart MF; Reed P; Weinkove C; Moriarty KJ; Ralston AJ
    J Clin Pathol; 1993 Mar; 46(3):280-2. PubMed ID: 8463426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of venous catheterization in the diagnosis and localization of bilateral phaeochromocytomas.
    Newbould EC; Ross GA; Dacie JE; Bouloux PM; Besser GM; Grossman A
    Clin Endocrinol (Oxf); 1991 Jul; 35(1):55-9. PubMed ID: 1889139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An association of primary aldosteronism and adrenaline-secreting phaeochromocytoma.
    Gordon RD; Bachmann AW; Klemm SA; Tunny TJ; Stowasser M; Storie WJ; Rutherford JC
    Clin Exp Pharmacol Physiol; 1994 Mar; 21(3):219-22. PubMed ID: 8076425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phaeochromocytoma: a ten-year survey.
    Loh KC; Shlossberg AH; Abbott EC; Salisbury SR; Tan MH
    QJM; 1997 Jan; 90(1):51-60. PubMed ID: 9093589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laboratory diagnosis of phaeochromocytoma: which analytes should we measure?
    Graham PE; Smythe GA; Edwards GA; Lazarus L
    Ann Clin Biochem; 1993 Mar; 30 ( Pt 2)():129-34. PubMed ID: 8466142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Twenty-four hour ambulatory blood pressure and heart rate in a patient with a predominantly adrenaline secreting phaeochromocytoma.
    Gallen IW; Taylor RS; Salzmann MB; Tooke JE
    Postgrad Med J; 1994 Aug; 70(826):589-91. PubMed ID: 7937455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidental adrenal mass hampers the diagnosis of an extra-adrenal phaeochromocytoma.
    Jeck T; Keller U
    Horm Res; 1996; 46(6):282-3. PubMed ID: 9064278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.